Clinical Trial Detail

NCT ID NCT02721875
Title Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

acute myeloid leukemia

bone marrow cancer

myelodysplastic syndrome

Therapies

Azacitidine

Volasertib

Age Groups: adult

No variant requirements are available.